Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1155
-
Total 13F shares, excl. options
-
257M
-
Shares change
-
+13.8M
-
Total reported value, excl. options
-
$24.4B
-
Value change
-
+$1.32B
-
Put/Call ratio
-
0.71
-
Number of buys
-
471
-
Number of sells
-
-437
-
Price
-
$94.69
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q4 2019
1,251 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q4 2019.
NOVARTIS AG - Ordinary Shares (NVS) has 1,155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 257M shares
of 2.18B outstanding shares and own 11.8% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (25.5M shares), Dodge & Cox (25.2M shares), FRANKLIN RESOURCES INC (11.8M shares), LOOMIS SAYLES & CO L P (10.3M shares), BANK OF AMERICA CORP /DE/ (9.37M shares), Fisher Asset Management, LLC (8.42M shares), UBS Group AG (8.08M shares), WELLS FARGO & COMPANY/MN (6.75M shares), RENAISSANCE TECHNOLOGIES LLC (6.6M shares), and Mawer Investment Management Ltd. (6.04M shares).
This table shows the top 1155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.